FWY003
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FWY003, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 2]